Human Beta-Defensin 3 Induces Maturation of Human Langerhans Cell–Like Dendritic Cells: An Antimicrobial Peptide that Functions as an Endogenous Adjuvant

Journal of Investigative Dermatology - Tập 133 - Trang 460-468 - 2013
Laura K. Ferris1, Yvonne K. Mburu2,3, Alicia R. Mathers1, Eric R. Fluharty1, Adriana T. Larregina1,3, Robert L. Ferris2,3,4, Louis D. Falo1,4
1Department of Dermatology, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, USA
2Department of Otolaryngology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA
3Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
4Cancer Immunology Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA

Tài liệu tham khảo

Berthier-Vergnes, 2005, TNF-[alpha] enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production, FEBS Lett, 579, 3660, 10.1016/j.febslet.2005.04.087 Biragyn, 2002, Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2, Science, 298, 1025, 10.1126/science.1075565 Chadebech, 2003, Use of human reconstructed epidermis to analyze the regulation of beta-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS, Cell Biol Toxicol, 19, 313, 10.1023/B:CBTO.0000004975.36521.c8 Davidson, 2004, The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization, J Immunol, 172, 1146, 10.4049/jimmunol.172.2.1146 De Smedt, 1996, Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo, J Exp Med, 184, 1413, 10.1084/jem.184.4.1413 Di Nardo, 2007, Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization, J Immunol, 178, 1829, 10.4049/jimmunol.178.3.1829 Feng, 2006, Cutting edge: human beta defensin 3 - a novel antagonist of the HIV-1 coreceptor CXCR4, J Immunol, 177, 782, 10.4049/jimmunol.177.2.782 Flacher, 2006, Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria, J Immunol, 177, 7959, 10.4049/jimmunol.177.11.7959 Funderburg, 2007, Human Beta-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2, Proc Natl Acad Sci, 104, 18631, 10.1073/pnas.0702130104 Geissmann, 1998, Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells, J Exp Med, 187, 961, 10.1084/jem.187.6.961 Gerstel, 2009, Rhamnolipid-induced shedding of flagellin from Pseudomonas aeruginosa provokes hBD-2 and IL-8 response in human keratinocytes, Cell Microbiol, 11, 842, 10.1111/j.1462-5822.2009.01299.x Guironnet, 2002, Antagonistic effects of IL-4 and TGF-{beta}1 on Langerhans cell-related antigen expression by human monocytes, J Leukoc Biol, 71, 845, 10.1189/jlb.71.5.845 Harder, 2001, Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic, J Biol Chem, 276, 5707, 10.1074/jbc.M008557200 He, 2006, Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization, Immunity, 24, 643, 10.1016/j.immuni.2006.03.014 Hollox, 2008, Psoriasis is associated with increased [beta]-defensin genomic copy number, Nat Genet, 40, 23, 10.1038/ng.2007.48 Joly, 2005, Correlation between beta-defensin expression and induction profiles in gingival keratinocytes, Mol Immunol, 42, 1073, 10.1016/j.molimm.2004.11.001 Kolls, 2008, Cytokine-mediated regulation of antimicrobial proteins, Nat Rev Immunol, 8, 829, 10.1038/nri2433 Larregina, 2005, Changing paradigms in cutaneous immunology: adapting with dendritic cells, J Investig Dermatol, 124, 1, 10.1111/j.1523-1747.2004.23554.x Larregina, 2001, Dermal-resident CD14+ cells differentiate into Langerhans cells, Nat Immunol, 2, 1151, 10.1038/ni731 Li, 2002, NF-[kappa]B regulation in the immune system, Nat Rev Immunol, 2, 725, 10.1038/nri910 Liu, 2002, Human [bgr]-Defensin-2 production in keratinocytes is regulated by Interleukin-1, bacteria, and the state of differentiation, J Invest Dermatol, 118, 275, 10.1046/j.0022-202x.2001.01651.x Liu, 2007, Psoriasis: genetic associations and immune system changes, Genes Immun, 8, 1, 10.1038/sj.gene.6364351 Mburu, 2011, Human beta-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck, Carcinogenesis, 32, 168, 10.1093/carcin/bgq236 Mburu, 2012, Chemokine receptor 7 (CCR7) gene expression is regulated by NF-kappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN), J Biol Chem, 287, 3581, 10.1074/jbc.M111.294876 Menzies, 2006, Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes, Infect Immun, 74, 6847, 10.1128/IAI.00389-06 Navid, 2012, Induction of regulatory T cells by a murine beta-defensin, J Immunol, 188, 735, 10.4049/jimmunol.1100452 Nomura, 2003, Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes, J Immunol, 171, 3262, 10.4049/jimmunol.171.6.3262 Ohl, 2004, CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions, Immunity, 21, 279, 10.1016/j.immuni.2004.06.014 Oppenheim, 2003, Roles of antimicrobial peptides such as defensins in innate and adaptive immunity, Ann Rheum Dis, 62, ii17 Rieser, 1997, Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production, J Exp Med, 186, 1603, 10.1084/jem.186.9.1603 Rohrl, 2010, Human {beta}-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2, J Immunol, 184, 6688, 10.4049/jimmunol.0903984 Semple, 2011, Human beta-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF, Eur J Immunol, 41, 3291, 10.1002/eji.201141648 Semple, 2010, Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo, Eur J Immunol, 40, 1073, 10.1002/eji.200940041 Sorensen, 2003, Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors, J Immunol, 170, 5583, 10.4049/jimmunol.170.11.5583 Tervaert, 1970, A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease, Dermatologica, 140, 282, 10.1159/000252565 Territo, 1989, Monocyte-chemotactic activity of defensins from human neutrophils, J Clin Invest, 84, 2017, 10.1172/JCI114394 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Wu, 2003, Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3, Proc Natl Acad Sci USA, 100, 8880, 10.1073/pnas.1533186100 Yang, 1999, Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6, Science, 286, 525, 10.1126/science.286.5439.525 Yang, 1999, Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-{beta}1 express functional C-C chemokine receptor 6, J Immunol, 163, 1737, 10.4049/jimmunol.163.4.1737